Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr:61:191-202.
doi: 10.1016/j.cbpa.2021.01.016. Epub 2021 Mar 30.

Biological activities of polypyridyl-type ligands: implications for bioinorganic chemistry and light-activated metal complexes

Affiliations
Review

Biological activities of polypyridyl-type ligands: implications for bioinorganic chemistry and light-activated metal complexes

Austin C Hachey et al. Curr Opin Chem Biol. 2021 Apr.

Abstract

Polypyridyl coordinating ligands are common in metal complexes used in medicinal inorganic chemistry. These ligands possess intrinsic cytotoxicity, but detailed data on this phenomenon are sparse, and cytotoxicity values vary widely and are often irreproducible. To provide new insights into the biological effects of bipyridyl-type ligands and structurally related metal-binding systems, reports of free ligand cytotoxicity were reviewed. The cytotoxicity of 25 derivatives of 2,2'-bipyridine and 1,10-phenanthroline demonstrates that there is no correlation between IC50 values and ligand properties such as pKa, log D, polarizability volume, and electron density, as indicated by NMR shifts. As a result of these observations, as well as the various reported mechanisms of action of polypyridyl ligands, we offer the hypothesis that biological effects are governed by the availability of and affinity for specific metal ions within the experimental model.

Keywords: 1,10-Phenanthroline; Chemotherapy; Copper; Iron; Ligand; Natural products; Polypyridyl; Ruthenium.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.. A) Timeline of studies on cytotoxic effects of bidentate polypyridyl ligands. B) and C) Bidentate free ligands discussed in this study.A)
2,2′-bipyridine (1) and derivative compounds 214 (blue). C) 1,10-phenanthroline (15) and derivative compounds 1625 (red). IC50 values (μM) in HL60 cells are included below compound numbers. The numbering schemes for 2,2′-bipyridine and 1,10-phenanthroline (red labels) and 13C-NMR (blue labels) are included (bottom-right inlay).
Figure 2.
Figure 2.. Proposed model of ligand induced cell death mechanisms.
Ortho-substituted ligands induce cell death. An apoptotic mechanism (top right), driven by ROS production and DNA damage, may compete simultaneously or in a [Cu] dependent manner with a paraptotic mechanism (top left), driven by the unfolded protein response, endoplasmic reticulum stress, and caspase inhibition. A metal-depletion-type mechanism (bottom) is hypothesized for unsubstituted systems.
Figure 3.
Figure 3.. The effect of trace copper contaminants on ligand cytotoxicity.
A. Cu homeostasis is strictly controlled to maintain cell health. Homeostasis is perturbed in the presence of a ligand, and cells experience the cytotoxic effect of Cu overload. B. Cytotoxicity values for 8 from 22 independent experiments collected in our laboratory over two months. Previously published A549 data are included as red triangles.[70, 90] C. In the absence of ligand, Cu levels in different batches of reagents vary but remain below the cytotoxic threshold. In the presence of an ionophoric ligand, different batches of media or FBS elicit cytotoxicity proportional to the metal concentration.
Chart 1.
Chart 1.. Structures of various compounds investigated with different mechanisms of action.
Colchicine (26) and Windaus’ Colchicine (27); Terpyridine (28), is cytotoxic with an IC50 of 2 μM[24]; Phendione (29) and Cuproinedione (30), which mediate Cu import, and perturb the GSH redox buffer[3]; 2,9-disecbutyl-1,10-phenanthroline (SBP) (31); Cu-pyrrolidine dithiocarbamate (32) and Hinokitiol (33) are ionophores that interfere with the ubiquitin-proteasome system[25, 26]; A Cu complex that activates the paraptotic pathway (34) [27]; c-Myc modulating compounds 35[28], APTO-253 (36), and Fe(APTO-253)3 (37). Ruthenium complexes: [Ru(bpy)2dmbpy]2+ (38); [Ru(dmphen)2]2+ scaffold (39); the third ligand can be any bidentate system; complexes 40–47; [Ru(dmbpy)2]2+ scaffold containing a 1H-imidazo[4,5-f][1,10]phenanthroline ligand appended to various conjugated groups (48–52); [Ru(phen)2dppz]2+ (53). The coordinating atoms of key ligands are highlighted by color.

Similar articles

Cited by

References

    1. Lipinski CA, Lead- and drug-like compounds: the rule-of-five revolution, Drug Discov Today Technol 1 (2004) 337–41. - PubMed
    1. Hoeschele JD, In remembrance of Barnett Rosenberg, Dalton Transactions (2009) 10648–50. - PubMed
    1. Naletova IS C; Curci A; Margiotta N; Natile G; Arena G; La Mendola D; Nicoletti VG; Rizzarelli E, Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells, Oncotarget 9 (2018) 36289–313. - PMC - PubMed
    2. This paper provides a detailed biological study of the mechanisms of actions of phendione and cuproinedione, and the metal-signaling systems these compounds perturb.

    1. Angel NR, Khatib RM, Jenkins J, Smith M, Rubalcava JM, Le BK, et al., Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity, J Inorg Biochem 166 (2017) 12–25. - PubMed
    1. Wachter E, Heidary DK, Howerton BS, Parkin S, Glazer EC, Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window, ChemComm 48 (2012) 9649–51. - PubMed

Publication types

LinkOut - more resources